LLY announcements Eli Lilly And Company announcements and dividends declared USA
Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY
Eli Lilly And Company LLY listed on USA and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Eli Lilly And Company LLY
Bull of the Day: Eli Lilly (LLY)
Eli Lilly has solidified itself as a global pharma titan. With leading drugs and a massive obesity market, Lilly is poised to be a juggernaut for years to come.
Announcement as on 09 January 2026
FDA Grants Full Approval To Eli Lilly's Jaypirca For CLL/SLL
(RTTNews) - Eli Lilly and Co. (LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Jaypirca (pirtobrutinib, 100 mg and 50 mg tablets) for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL
Announcement as on 04 December 2025
Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales
LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 blockbusters.
Announcement as on 20 November 2025
Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales
LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 blockbusters.
Announcement as on 20 November 2025
Eli Lilly wants to be part of making a big dent in obesity and diabetes, says co's India head Winselow Tucker
Eli Lilly India chief Winselow Tucker said the company’s strategy of combining a strong product with ecosystem partnerships and patient education has helped drive early momentum for Mounjaro in India, where the dual-action diabetes and obesity drug has clo
Announcement as on 19 November 2025
Announcements by Eli Lilly And Company first page | Next page |
LLY Eli Lilly And Company current price & indicator signals
Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 16 Fri Jan 2026 | 1038.94 | 1018.00 to 1049.94 | 0.62% | 0.64 times |
| 15 Thu Jan 2026 | 1032.51 | 1012.57 to 1071.45 | -3.85% | 1.11 times |
| 14 Wed Jan 2026 | 1073.81 | 1061.12 to 1084.00 | -0.31% | 0.4 times |
| 13 Tue Jan 2026 | 1077.19 | 1069.09 to 1090.22 | -0.32% | 0.91 times |
| 12 Mon Jan 2026 | 1080.66 | 1058.00 to 1083.36 | 1.61% | 0.51 times |
| 09 Fri Jan 2026 | 1063.56 | 1063.03 to 1104.52 | -1.95% | 0.57 times |
| 08 Thu Jan 2026 | 1084.68 | 1070.15 to 1133.95 | -2.11% | 0.72 times |
| 07 Wed Jan 2026 | 1108.09 | 1075.96 to 1117.66 | 4.14% | 1.94 times |
| 06 Tue Jan 2026 | 1064.04 | 1039.93 to 1070.83 | 2.16% | 1.12 times |
| 05 Mon Jan 2026 | 1041.51 | 1033.38 to 1085.38 | -3.6% | 1.7 times |
| 02 Fri Jan 2026 | 1080.36 | 1052.08 to 1080.66 | 0.49% | 1.03 times |
| 31 Wed Dec 2025 | 1075.06 | 1074.43 to 1083.50 | -0.45% | 0.27 times |
Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


